4/A//SEC Filing
Longcor Jarrod 4/A
Accession 0001104659-20-029695
CIK 0001279704other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:01 PM ET
Size
5.9 KB
Accession
0001104659-20-029695
Insider Transaction Report
Form 4/AAmended
Longcor Jarrod
Chief Operating Officer
Transactions
- Award
Stock option (right to buy)
2020-02-03+40,000→ 40,000 totalExercise: $2.71Exp: 2030-02-03→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]This Form 4/A is being filed to correct a Form 4 filed on February 4, 2020, in which the stock option grant was reported as a common stock grant. The underlying value of the award remains unchanged.
- [F2]Stock options vest in equal annual increments on February 3, 2021, February 3, 2022, and February 3, 2023.
Documents
Issuer
Cellectar Biosciences, Inc.
CIK 0001279704
Entity typeother
Related Parties
1- filerCIK 0001545565
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:01 PM ET
- Size
- 5.9 KB